ArticlePediatric nephrology (Berlin, Germany)2021

Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis.

Winnie Sohn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.